Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for neurological outcome after spinal cord injury
IRCT20120527009878N15Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, triple-blind trial of minocycline in spinal cord injury (SCI) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Neurological status based on Frankel Grade. Started Oct 2022; status: completed.
02
Drugs
minocycline
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on IRCT20120527009878N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120527009878N15.